2m 2m 2m 2m 2m 2m 2m
- $54,412.00Market Cap
- 1,300.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
THC Therapeutics (THCT)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 51
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery
THC Therapeutics has acquired SugarTop Buddery, a cannabis brand based in Eugene, Oregon, for approximately $3 million in an all-share transaction. The acquisition expands THCT's operations in Oregon and adds a respected craft cannabis company to its portfolio.
07/09/2025, 8:30 AM • Benzinga
THC Therapeutics, Inc. has acquired The Headquarters Group, Inc., a holding company with a portfolio of cannabis-related businesses in genetics, cultivation, extraction, and distribution, as well as specialty real estate and nutrients. The combined company aims to leverage its expertise and resources to expand its operations in the regulated cannabis industry.
06/24/2025, 8:30 AM • Benzinga
Peers
Statistics
MoreInformation as of 05/21/2026
Company Profile
THC Therapeutics, Inc. operates in the wellness industry. It develops dHydronator, a sanitizing herb/cannabis dryer for the drying and sanitizing of freshly harvested cannabis, herbs, flowers, and tea leaves. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was founded in 2007 and is based in Jacksboro, Texas.
Key Executives
- Victor Nacif
- Scott Cox
Current Ownership Distribution
- Insiders29.6M (76.27%)
- Other9.2M (23.73%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)